Listeriosis is uncommon in recipients of allogeneic blood, marrow and organ transplantation. Six patients with systemic Listeria monocytogenes infection during 1985-1997 at Bone Marrow Transplantation Service, Memorial Sloan-Kettering Cancer Center are described. In two male and four female patients, the median duration from transplantation to isolation of L. monocytogenes was 62.5 (range 29 to 821) days. Among five allogeneic marrow transplant recipients, four (80%) received HLA antigen matched, T cell-depleted grafts from three unrelated and a single related donor. One patient underwent mismatched-related marrow graft transplant. Cord stem cell transplantation was performed in a single patient. Two required therapy for graftversus-host disease (GVHD). The 13 year incidence of systemic Listeria infections was 0.47 percent. All six presented with fever (Ͼ39؇C), and L. monocytogenes bloodstream invasion. Mental status changes and meningioencephalitis were observed in two (33.3%). A concurrent primary opportunistic infection was present in five individuals (83.3%), and four (80%) were being treated for acute human cytomegalovirus (HCMV) viremia. Sixty-six percent responded to therapy and two died from unrelated, non-listeric causes. Systemic listeriosis was uncommon in our high-risk allogeneic blood and marrow transplantation population, and response to therapy with parenteral ampicillin and gentamicin was excellent. The association between primary HCMV reactivation and subsequent listeric infection emphasizes the significance of HCMV-related dysfunction in 
Systemic listeriosis is an infrequent infection even in highly susceptible patients with profound suppression of cellular immunity. 1, 2 In allogeneic transplant recipients with severe CD4 + T cell defects, systemic Listeria monocytogenes infection is seldom seen. [2] [3] [4] Reactivation of human cytomegalovirus (HCMV), on the other hand, is not uncommon in patients undergoing allogeneic blood, marrow or organ transplants and is associated with a marked increase in short-term morbidity and mortality. 5, 6 Reactivation of HCMV is associated with impairment of T lymphocyte recovery due to virus-related marrow aplasia, and graft failure. 7 Virus mediated suppression of T lymphocyte-dependent immune responses, which include delayed regeneration of certain lymphocyte subsets, up-regulation of Th-2 cytokines, suppression of interferon-gamma, interleukin-2 (IL-2) secretion and hyporesponsiveness of CD3 + receptormediated T cell activation may increase the risk of secondary opportunistic infections. [8] [9] [10] [11] However, association of increased risk of systemic listerosis in recipients of allogeneic BMT with HCMV reactivation has not been described.
We report six patients with hematogenous L. monocytogenes infection following allogeneic blood and marrow transplantation during 13 years at a comprehensive cancer center in New York.
Bone Marrow Transplantation

Patients and methods
Study design
Six allogeneic blood or marrow graft recipients with systemic L. monocytogenes infection were retrospectively evaluated at Memorial Sloan-Kettering Cancer Center from 1 January 1985 to 31 December 1997. Patient and laboratory information were retrieved from hospital charts, and computerized hospital data systems. L. monocytogenes reidentification and serotypes were analyzed at the Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. All values are expressed as medians and ranges.
Patients, conditioning regimens and GVHD prohylaxis
Five patients received allogeneic marrow grafts according to protocols outlined in previous reports. 12, 13 Cord stem cell transplantation and the pre-transplantation preparatory regimen was previously reported. 14 
Isolation of L. monocytogenes
All gram-positive coccobacilli isolated from deep ␤-hemolytic colonies on Columbia Sheep Blood agar (BBL; Becton Dickinson, Sparks, MD, USA) after aerobic incubation at 37°C (pH 7.2-7.4) were further evaluated. Catalase producing, short gram-positive bacteria were tested for motility at temperatures of 24 and 37°C. Bacteria with tumbling motility at room temperature (24°C) following sub-culture on Bile Esculin Blood agar slants (BBL; Becton Dickinson, Sparks, MD) were confirmed as L. monocytogenes.
Results
One thousand, three hundred and fifteen allogeneic transplants were performed from 1 January 1985 to 31 December 1997 at the Bone Marrow Transplantation Service, Memorial Sloan-Kettering Cancer Center. The incidence of listerosis during 13 years was 0.47 percent. During this period, infection due to L. monocytogenes was not observed in patients undergoing autologous or syngeneic transplants. The interval from allogeneic graft transplantation to isolation of L. monocytogenes was 62.5 (29-821) days. Table 1 illustrates the characteristics of patients with systemic listerosis. In two male and four female patients age was 24.5 (8-50) years. All six had intact granulocyte counts (median white cell count 7300 (17 400-2600) cells/mm) 3 . In three patients with myelodysplastic syndrome, one patient had refractory anemia with excess blasts in transformation. Two individuals received allogeneic marrow grafts for chronic myelogenous leukemia and cord stem cell transplantation was performed due to refractory acute myelogenous leukemia. In five marrow transplant recipients, four (80%) received HLA antigen-matched grafts from three unrelated and a single related donor. One each was given related donor marrow, mismatched (2/6 antigen mismatched) marrow and a cord stem cell graft. Four received T cell-depleted marrow grafts. Two (33.3%) patients were receiving a corticosteroid and cyclosporin A-based regimen for severe (III-IV) GVHD involving the gastrointestinal tract and skin. Acute GVHD in patient 4 was treated with cyclosporin A (CsA), prednisone, and anti-thymocyte globulin. All three patients that were evaluated for CD4 + T cells showed profound helper cell lymphocytopenia (10, 29 and 114 cells/mm 3 ) ( Table  2) . High-grade fever (Ͼ39°C) and L. monocytogenes bloodstream invasion was present in all six patients. New and sudden neurological changes including cognitive dysfunctions, confusion and obtundation were present in two (33.3%). One patient (patient 1) had evidence of listeric meningioencepahlitis and computed tomography scan confirmed global diffuse cerebritis (Table 2) . A concurrent primary opportunistic infection was present in five individuals (83.3%). Four (80%) had evidence of HCMV reactivation. HCMV viremia was measured by either shell-vial cultures, or peripheral blood pp65 buffy-coat antigenemia assays. Patient 1 was receiving intravenous IL-2 infusions for rapidly progressive multifocal leukoencephalopathy, BK/JCV was confirmed on electron microscopic examination of cerebrospinal fluid (Table 2 ).
All patients received intravenous ampicillin (12 g daily). Gentamicin (5 mg/kg daily, adjusted for renal dysfunction) was included for antimicrobial synergy in five. 15 Total duration of antimicrobial therapy ranged from 12 to 42 days (median 25 days). Four patients (66.7%) responded to treatment. After 15 days of intravenous ampicillin and gentimicin, patient 3 experienced clinical relapse associated with fever, headache and confusion while on oral ampicillin (500 mg every 6 h). She responded to a subsequent course of parentral ampicillin and gentamicin given for 6 weeks. No listerosis-related late sequelae were noticed (Table 2) . Two patients expired. In patient 4, progressive CMV pneumonitis and adult respiratory distress syndrome was regarded as the terminal event, while another patient succumbed to persistent, polymicrobial, gram-negative septicemia due to Escherichia coli and Klebsiella spp 37 days after isolation of L. monocytogenes from her bloodstream ( Table 2 ).
Discussion
L. monocytogenes is a rare cause of serious morbidity in patients with profound cellular immune defects. 1,2 The overall incidence of listerosis during 13 years at our institution (0.47 percent) was comparable to that reported from the Royal Marsden Hospital, UK during 1972 to 1994. The percent incidence of listerosis in all marrow transplants performed at their center was 0.39 and 0.42 in recipients of allogeneic marrow grafts and was virtually identical to the current report. 3 Recipients of allogeneic marrow and solid organ transplantation are at additional risk of disease due to opportunistic, facultative intracellular pathogens such as L. monocytogenes, Nocardia asteroids, Legionella pneumophila and Salmonella spp. 2, [16] [17] [18] [19] Most of these opportunistic bacterial infections are observed during the early marrow engraftment period (30 to 180 days). 16, 19 In patients undergoing antimicrobial prophylaxis and myelosuppressive treatment for acute (patient 4) or acute exacerbation of chronic GVHD (patient 1) these opportunistic infections may be delayed (Ͼ360 days post BMT). 1, 2, 11, 18, 19 The interval from marrow transplantation to diagnosis of listerosis has been reported to be from (median, range) 8, 5-540, 20 84, 56-728, 3 to 210, 120-2700 days. 21 This interval was comparable in our patients (62.5, 29-821 days) including patient 1 who developed listeric meningioencephalitis/cereb ritis 91 days after receiving related donor stem cells transfusion ( Table 2) .
The risk of systemic L. monocytogenes infection is extremely low even in high-risk settings. However, in patients with compromised T cell-dependent immunity, the life-time risk of listeric infections is estimated to be 100-to 300-fold higher than in the general population. 22, 23 Routine broad-spectrum antimicrobial prophylaxis with trimethoprim-sulfamethoxazole and ciprofloxacin may confer protection in individuals at risk, including those undergoing Bone Marrow Transplantation transplantation. [2] [3] [4] 21, [24] [25] [26] Alternatively, the pre-activated macrophages during the early phase following transplantation may provide effective containment of these opportunistic intracellular pathogens 27, 28 and play a critical role in the paucity of infection due to L. monocytogenes, Legionella pneumophila, Nocardia asteroids and Salmonella spp, in this setting. The near-optimal nonspecific immune responses due to activated macrophages, and intact natural killer cell activity 28, 29 seen in autologous and syngeneic graft transplant recipients may in part explain the absence of listerosis in this subgroup of patients at our institution. Listeric meningoencephalitis is the most frequent complication of systemic L. monocytogenes infection, especially in patients with compromised immunity. 3, 21 In contrast, we report central nervous system involvement in only one-third of allogeneic blood and marrow graft recipients with systemic listerosis (Table 2) , consistent with the observation reported from Barcelona, Spain. 20 Nearly onethird to half of transplant recipients succumbed to systemic L. monocytogenes infections. 3, 20 In our group, no deaths were attributed to listeriosis, which was in concert with observations reported by Long et al. 21 Reactivation of a latent Herpesviridae infection following allogeneic transplantation has been recognized as a common cause of serious morbidity and death. 5, 6, 10, 11, 19 High-grade HCMV viremia is associated with marked suppression in T lymphocyte functions. [7] [8] [9] We suspect, that HCMV-induced dysfunction of innate immunity including natural killer cells and impaired handling of intracellular pathogens by the tissue macrophages due to sub-optimal priming by Th-1 cytokines may have contributed to the evasion of primary and secondary host defenses against L. monocytogenes in our transplant recipients.
In conclusion, systemic listeriosis is rare in patients undergoing allogeneic blood and marrow transplantation. These opportunistic infections may be encountered as early as the second week after transplantation, although most infections are seen beyond 60 days post BMT. Bloodstream invasion was universal in our group, and involvement of central nervous system was infrequent. Reactivation of human cytomegalovirus infection appears to have a significant role in promoting the risk for secondary opportunistic infections including hematogenous listerosis following allogeneic blood/marrow transplantation.
